Orivam News from the source.

Research notes

What India's research desks published, reported with attribution and linked to the original notes. Orivam issues no recommendations of its own.

1 note from Motilal Oswal · since 01 Nov 2026, 00:00 IST

01 Nov 2026, 16:12 IST IOCL Motilal Oswal Neutral target INR135

The report states that IOCL's 2QFY27 EBITDA of INR303b and PAT of INR216b beat estimates due to better-than-estimated marketing performance, but cuts FY27 EBITDA estimate to INR412b from INR576b on expected marketing margin pressure ahead of state elections, and reiterates a Neutral rating with a target price of INR135 based on 4.5x Dec'27 EBITDA plus investment value.

Read this note →